Compounds > 1,2,4-triazine
Page last updated: 2024-08-24

1,2,4-triazine and Myeloproliferative Disorders

1,2,4-triazine has been researched along with Myeloproliferative Disorders in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albom, MS; Angeles, TS; Breslin, HJ; Dorsey, BD; Gingrich, DE; Huang, Z; Lisko, JG; Mason, JL; Milkiewicz, KL; Thieu, TV; Underiner, TL; Weinberg, LR; Wells, GJ; Wells-Knecht, KJ1

Other Studies

1 other study(ies) available for 1,2,4-triazine and Myeloproliferative Disorders

ArticleYear
2,7-Pyrrolo[2,1-f][1,2,4]triazines as JAK2 inhibitors: modification of target structure to minimize reactive metabolite formation.
    Bioorganic & medicinal chemistry letters, 2011, Dec-15, Volume: 21, Issue:24

    Topics: Amino Acid Substitution; Glutathione; Humans; Janus Kinase 2; Myeloproliferative Disorders; Protein Kinase Inhibitors; Pyrroles; Structure-Activity Relationship; Triazines

2011